NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study

Mostrar otras versiones (1)

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to reduce pain, fever, and inflammation but have been associated with complications in community-acquired pneumonia. Observations shortly after the start of the COVID-19 pandemic in 2020 suggested that ibuprofen was associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Reese, Justin T., Coleman, Ben, Chan, Lauren, Blau, Hannah, Callahan, Tiffany J., Cappelletti, Luca, Fontana, Tommaso, Bradwell, Katie R., Harris, Nomi L., Casiraghi, Elena, Valentini, Giorgio, Karlebach, Guy, Deer, Rachel, McMurry, Julie A., Haendel, Melissa A., Chute, Christopher G., Pfaff, Emily, Moffitt, Richard, Spratt, Heidi, Singh, Jasvinder A., Mungall, Christopher J., Williams, Andrew E., Robinson, Peter N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107579/
https://www.ncbi.nlm.nih.gov/pubmed/35570298
http://dx.doi.org/10.1186/s12985-022-01813-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107579/
https://www.ncbi.nlm.nih.gov/pubmed/35570298
http://dx.doi.org/10.1186/s12985-022-01813-2

Ejemplares similares